STOCK TITAN

Cardlytics Stock Price, News & Analysis

CDLX Nasdaq

Welcome to our dedicated page for Cardlytics news (Ticker: CDLX), a resource for investors and traders seeking the latest updates and insights on Cardlytics stock.

Cardlytics (CDLX) delivers purchase-based advertising intelligence through partnerships with financial institutions, transforming consumer spending data into actionable marketing insights. This news hub provides investors and analysts with essential updates on the company’s evolving strategies in digital advertising and data analytics.

Access real-time announcements including quarterly earnings, product launches, and partnership expansions. Our curated collection features press releases about platform innovations, client acquisitions, and industry recognition – all critical developments for understanding CDLX’s market position.

Key updates cover operational milestones across both core platforms: the proprietary bank advertising channel and Bridg cloud-based analytics solutions. Track developments in campaign measurement capabilities, financial institution collaborations, and data security enhancements that shape the company’s competitive edge.

Bookmark this page for streamlined monitoring of CDLX’s financial performance and strategic initiatives. Combine our news feed with SEC filings and earnings call transcripts available through Stock Titan’s financial research tools for comprehensive analysis.

Rhea-AI Summary

Cardlytics, Inc. announced their first quarter 2024 financial results, showcasing a 5% increase in revenue, 10% growth in billings, and a 20% rise in adjusted contribution year-over-year. Despite a net loss, the company saw positive adjusted EBITDA and improvement in balance sheet, with strong momentum in international business.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-36.51%
Tags
-
Rhea-AI Summary

Cardlytics, Inc. announced the grant of 38,500 restricted stock units to five new employees as inducements for employment. The grants were made under the 2022 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4). The restricted stock units have different vesting schedules, with some vesting in full after one year and others vesting partially over a period of 12 months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.51%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.98%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.65%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-32.84%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
77.15%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.06%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.21%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.61%
Tags

FAQ

What is the current stock price of Cardlytics (CDLX)?

The current stock price of Cardlytics (CDLX) is $1.88 as of August 1, 2025.

What is the market cap of Cardlytics (CDLX)?

The market cap of Cardlytics (CDLX) is approximately 107.6M.
Cardlytics

Nasdaq:CDLX

CDLX Rankings

CDLX Stock Data

107.63M
51.06M
2.74%
55.22%
12.22%
Advertising Agencies
Services-computer Programming, Data Processing, Etc.
Link
United States
ATLANTA